/
STIM
$2.80-$0.10 (-3.61%)prev close
Change$-3.64
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$213.4M
76M shares
52-week range
$0.80 – $3.44
76% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
P/S (TTM)
1.3
Neuronetics, Inc. Common Stock
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
www.neurostar.com- Employees
- 658
- IPO / List date
- Jun 28, 2018
- HQ
- MALVERN, PA
Held by traders on TradeandTell
No one on the platform currently holds STIM.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 474,900 | $655.4K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded STIM yet.
